According to a report issued by the Food and Drug Administration (FDA) last week, a recent study of 11 drugs concluded that the class of medications known as "antiepileptics" carries an increased risk of suicidal thoughts and behaviors. Antiepileptics are used to treat epilepsy, bipolar disorder, migraine headaches, among other conditions. The study concluded that patients taking antiepileptics had roughly double the risk of suicidal thoughts and behaviors compared to those who were given placebos.
Although only 11 drugs were used in the study, the FDA expects that all medicines classified as antiepileptics share the increased risk of "suicidality." Patients currently taking antiepileptics are advised to speak with their health care provider before making any changes. The FDA also encouraged the family and friends of those on antiepileptics to remain alert to any signs of suicidal behavior.